PLX Dror Bashan bought Protalix BioTherapeutics, Inc. shares — SEC Form 4BUYProtalix BioTherapeutics, Inc.

Dror Bashan, PRESIDENT AND CEO at Protalix BioTherapeutics, Inc. (PLX), bought 56,000 shares at $1.81 ($101K) on 2025-12-19, disclosed to the SEC on 2025-12-23.

SEC EDGAR Filing

0001781450-25-000005

View on SEC EDGAR

Why this matters (generating…)

High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.

Modest59/100

Nothing distinguishes this filing.

Large Holdings IncreaseOpportunistic Buy

Trade Context

•Increased holdings by 42%
•2nd largest purchase, out of 3
•Last purchase was 792 days ago
•Stock up +28% in previous 6 months

Filing Info

Filed2025-12-23

Traded2025-12-19

Accession0001781450-25-000005

SourceSEC EDGAR (Historical)

Insider

NameDror Bashan

TitlePRESIDENT AND CEO

PIT GradeInsiderC

Score—

View Company View Insider

Related Trades by This Insider

Ticker	Type	Filed	Value	7d Stock	Filing
PLX	BUY	2023-10-20	$158K	—	Filing →
PLX	BUY	2022-04-13	$102K	—

Get an email when an insider at PLX files

Free account. Follow PLX and up to 10 more companies.

Follow PLX for free

PLX Dror Bashan bought Protalix BioTherapeutics, Inc. shares — SEC Form 4BUYProtalix BioTherapeutics, Inc.

Trade Context

Filing Info

Insider

Related Trades by This Insider

Trade Details

Outcomes